BRIEF-CorMedix Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Reuters
25 Mar
BRIEF-CorMedix Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

March 25 (Reuters) - CorMedix Inc CRMD.O:

  • CORMEDIX Q4 BASIC EPS USD 0.22

  • CORMEDIX Q4 NET INCOME USD 13.5 MILLION

  • CORMEDIX Q4 OPERATING EXPENSES USD 17.1 MILLION

  • CORMEDIX INC - TO COMMENCE PHASE 3 STUDY OF DEFENCATH IN Q2 2025

  • CORMEDIX INC - PRELIM NET REVENUE GUIDANCE FOR H1 2025 $50 MILLION - $60 MILLION

Source text: ID:nGNX6Kw1Nk

Further company coverage: CRMD.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10